12-49033555-T-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS2
The NM_003482.4(KMT2D):c.11150A>C(p.Gln3717Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000682 in 1,613,416 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q3717R) has been classified as Benign.
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Publications
- choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndromeInheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
- Kabuki syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Kabuki syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2D | NM_003482.4 | c.11150A>C | p.Gln3717Pro | missense_variant | Exon 40 of 55 | ENST00000301067.12 | NP_003473.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2D | ENST00000301067.12 | c.11150A>C | p.Gln3717Pro | missense_variant | Exon 40 of 55 | 5 | NM_003482.4 | ENSP00000301067.7 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152072Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248342 AF XY: 0.00000741 show subpopulations
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461344Hom.: 0 Cov.: 46 AF XY: 0.00 AC XY: 0AN XY: 726962 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152072Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74296 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Kabuki syndrome 1 Uncertain:1
not provided Uncertain:1
KMT2D-related disorder Uncertain:1
The KMT2D c.11150A>C variant is predicted to result in the amino acid substitution p.Gln3717Pro. This variant was reported as uncertain significance in an individual with unspecified phenotypes from a study investigating Kabuki syndrome-specific epigenome signature. However, this variant was not considered to share the epigenome signature as seen in other pathogenic loss-of-function KMT2D variants (Sample KMT2D-24 in Table S5, Butcher et al. 2017. PubMed ID: 28475860). This variant is present in two out of ~248,000 alleles in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.
Kabuki syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at